Nordic Business Report-April 24, 2006-Hansa Medical AB acquires patent portfolio from Leukotech A/S
(C)1994-2006 M2 COMMUNICATIONS LTD http://www.m2.com
The Swedish life sciences research group Biolin AB said on Monday (24 April) that its wholly-owned subsidiary Hansa Medical AB has acquired an antibody patent portfolio from Danish biopharmaceutical company Leukotech A/S.
The patents relate to antibodies against heparin binding protein (HBP) and biologically active peptides.
No financial details were disclosed.
((Comments on this story may be sent to firstname.lastname@example.org))